Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Anti-Rabies Virus Conjugates Supply Update

Posted: November 17, 2010

laboratory worker examining test results with a microscope

In the U.S., the national standard protocol for post-mortem diagnosis of rabies requires the use of two anti-rabies virus conjugates (containing different antibodies) in each test.

Although there are five commercial anti-rabies virus reagents available in the U.S., three products (Fujirebio Diagnostics 800-092, Millipore Corporation 5500, and Millipore Corporation 6500) contain the same antibodies, and therefore may not be used together in a diagnostic test. This limits pairing options for one of the aforementioned products with Millipore Corporation 5100 or Millipore Corporation 5199. When supplies of rabies conjugates are in short supply, the ability to perform reliable rabies diagnosis is affected.

Recently, CDC was informed that some public health laboratories have encountered problems obtaining Millipore Monoclonal Anti-Rabies DFA Reagent (5100), which was on backorder. According to the manufacturer, there is now a sufficient supply available, and backorders are being filled promptly.

Please contact CDC if you should encounter problems related to this or other rabies diagnostic issues.

CDC Rabies Program: (404) 639-1050.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • New Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
We help prevent rabies
CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO